Medpace Holdings Total Liabilities 2014-2025 | MEDP

Medpace Holdings total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Medpace Holdings total liabilities for the quarter ending September 30, 2025 were $1.459B, a 21.35% increase year-over-year.
  • Medpace Holdings total liabilities for 2024 were $1.275B, a 16.16% increase from 2023.
  • Medpace Holdings total liabilities for 2023 were $1.098B, a 13.64% increase from 2022.
  • Medpace Holdings total liabilities for 2022 were $0.966B, a 36.65% increase from 2021.
Medpace Holdings Annual Total Liabilities
(Millions of US $)
2024 $1,275
2023 $1,098
2022 $966
2021 $707
2020 $585
2019 $417
2018 $378
2017 $447
2016 $368
2015 $571
2014 $695
2013 $0
Medpace Holdings Quarterly Total Liabilities
(Millions of US $)
2025-09-30 $1,459
2025-06-30 $1,399
2025-03-31 $1,304
2024-12-31 $1,275
2024-09-30 $1,203
2024-06-30 $1,156
2024-03-31 $1,124
2023-12-31 $1,098
2023-09-30 $1,016
2023-06-30 $1,016
2023-03-31 $1,048
2022-12-31 $966
2022-09-30 $979
2022-06-30 $1,032
2022-03-31 $739
2021-12-31 $707
2021-09-30 $679
2021-06-30 $618
2021-03-31 $592
2020-12-31 $585
2020-09-30 $505
2020-06-30 $484
2020-03-31 $420
2019-12-31 $417
2019-09-30 $380
2019-06-30 $359
2019-03-31 $385
2018-12-31 $378
2018-09-30 $388
2018-06-30 $428
2018-03-31 $462
2017-12-31 $447
2017-09-30 $399
2017-06-30 $356
2017-03-31 $345
2016-12-31 $368
2016-09-30 $366
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2014-12-31 $695
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $16.564B $2.109B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $165.999B 30.48
HCA Healthcare (HCA) United States $107.452B 17.79
CVS Health (CVS) United States $105.376B 12.12
Elevance Health (ELV) United States $82.464B 12.09
Cencora (COR) United States $68.573B 22.11
Natera (NTRA) United States $33.416B 0.00
DiDi Global (DIDIY) China $23.344B 21.57
Labcorp Holdings (LH) United States $22.106B 16.86
EUROFINS SCIENT (ERFSF) Luxembourg $16.437B 0.00
Viatris (VTRS) United States $15.215B 5.67
ICON (ICLR) Ireland $15.077B 14.96
BioMerieux (BMXMF) France $14.360B 0.00
Solventum (SOLV) United States $13.687B 13.28
Revvity (RVTY) United States $13.234B 24.37
CochLear (CHEOY) Australia $12.390B 0.00
Charles River Laboratories (CRL) United States $10.808B 20.82
Avantor (AVTR) United States $8.045B 12.29
Sonic Healthcare (SKHHY) Australia $7.967B 0.00
HealthEquity (HQY) United States $7.186B 26.87
BrightSpring Health Services (BTSG) United States $7.149B 42.62
Caris Life Sciences,�Inc (CAI) United States $7.054B 0.00
Bausch + Lomb (BLCO) Canada $6.014B 39.49
PACS (PACS) United States $5.477B 33.30
Sotera Health (SHC) United States $5.259B 25.36
Alignment Healthcare (ALHC) United States $4.764B 0.00
Amplifon S.p.A (AMFPF) Italy $3.719B 21.70
GeneDx Holdings (WGS) United States $2.930B 51.45
Concentras Parent (CON) United States $2.762B 17.24
Organon (OGN) United States $2.537B 2.67
Progyny (PGNY) United States $2.174B 42.75
Surgery Partners (SGRY) United States $2.088B 26.90
Establishment Labs Holdings (ESTA) United States $1.916B 0.00
Pediatrix Medical (MD) United States $1.850B 11.05
Ardent Health (ARDT) United States $1.226B 4.00
Teladoc Health (TDOC) United States $1.123B 0.00
Nutex Health (NUTX) United States $1.105B 8.45
CareDx (CDNA) United States $1.050B 17.16
Omada Health (OMDA) United States $0.957B 0.00
GoodRx Holdings (GDRX) United States $0.869B 14.22
InnovAge Holding (INNV) United States $0.791B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.688B 0.00
Embecta (EMBC) United States $0.648B 3.68
Sonida Senior Living (SNDA) United States $0.592B 0.00
Enhabit (EHAB) United States $0.546B 24.52
CryoPort (CYRX) United States $0.520B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
Strata Critical Medical (SRTA) United States $0.472B 0.00
SBC Medicals (SBC) United States $0.448B 8.25
Auna S.A (AUNA) Luxembourg $0.419B 6.74
Agilon Health (AGL) United States $0.411B 0.00
Oncology Institute (TOI) United States $0.328B 0.00
QDM (QDMI) Hong Kong, SAR China $0.320B 67.24
Shoulder Innovations (SI) United States $0.307B 0.00
So-Young (SY) China $0.291B 0.00
Beauty Health (SKIN) United States $0.195B 0.00
KindlyMD (NAKA) United States $0.177B 0.00
LifeMD (LFMD) United States $0.172B 0.00
Ascend Wellness Holdings (AAWH) United States $0.135B 0.00
Sera Prognostics (SERA) United States $0.125B 0.00
Biodesix (BDSX) United States $0.093B 0.00
DocGo (DCGO) United States $0.082B 0.00
Park Dental Partners (PARK) United States $0.079B 0.00
IceCure Medical (ICCM) Israel $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.043B 0.00
Pomdoctor - (POM) China $0.029B 0.00
Synergy CHC (SNYR) United States $0.021B 6.41
OSR Holdings (OSRH) United States $0.021B 0.00
Basel Medical Group (BMGL) Singapore $0.015B 0.00
Lifeward (LFWD) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
ITonic Holdings (ITOC) China $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00
XWELL (XWEL) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.000B 0.00
Cano Health (CANOQ) United States $0.000B 0.00